7. Rajkumar SV, Jacobus S, Callander NS, et al for the Eastern Cooperative Oncology Group. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasoneas initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.